A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be ...

Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.

The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

Abdominal aortic aneurysm (AAA) repair has undergone a remarkable transformation over the last 2 decades, primarily driven by ...

• Antibiotics seem to reduce surgical site infections in people undergoing aortic or aortoiliac surgery. • Other interventions assessed appear to make little or no difference in reducing the incidence ...

Compared with usual care, a system of electronic provider notification more often enabled patients diagnosed with severe ...

Edwards Lifesciences (NYSE: EW) today announced eight-year data highlighting positive long-term outcomes with its proprietary ...

Edwards Lifesciences (EW) announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary ...

Edwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESILIA tissue technology have significantly ...

The Heart Valve Devices Market is valued at USD 12.18 Billion in 2024 and is expected to reach USD 41.88 Billion by 2035 at a ...

The aorta is widest at the point where it connects to the heart's left ventricle through the aortic valve; then, it gets progressively narrower as it descends into the abdomen. The aorta is divided ...